PETS

1.82

2.25% 0.04

Handel nachbörslich: 1.83 0.01 +0.55%

Petmed Express Inc (PETS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PETS? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$1.78

Offen:

$1.8

24-Stunden-Volumen:

192.50K

Relative Volume:

1.80

Marktkapitalisierung:

$38.89M

Einnahmen:

$182.67M

Nettoeinkommen (Verlust:

$-64.87M

KGV:

-0.5835

EPS:

-3.1193

Netto-Cashflow:

$-22.92M

1W Leistung:

-17.27%

1M Leistung:

-19.82%

6M Leistung:

+4.60%

1J Leistung:

-53.81%

1-Tages-Spanne:

$1.78

$1.83

1-Wochen-Bereich:

$1.75

$2.27

52-Wochen-Spanne:

$1.57

$4.32

Petmed Express Inc Stock (PETS) Company Profile

Firmenname

Petmed Express Inc

Sektor

Healthcare (1105)

Branche

Pharmaceutical Retailers (7)

Telefon

(561) 426-4444

Adresse

420 SOUTH CONGRESS AVENUE, DELRAY BEACH

Mitarbeiter

173

Twitter

@1800petmeds

Nächster Verdiensttermin

2026-06-02

Neueste SEC-Einreichungen

PETS's Discussions on Twitter

Compare PETS vs HITI, SCNX, POM, WGRX

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PETS Petmed Express Inc	1.82	38.03M	182.67M	-64.87M	-22.92M	-3.1193
HITI High Tide Inc	2.38	203.92M	452.61M	-35.30M	13.25M	-0.3863
SCNX Scienture Holdings Inc	0.38	15.44M	653.40K	-20.19M	-11.11M	-1.8091
POM Pomdoctor Ltd Adr	0.1003	13.62M	0	0	0	0.00
WGRX Wellgistics Health Inc	4.29	11.03M	23.34M	-101.27M	-11.74M	-1.2919

Petmed Express Inc Stock (PETS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-05-25	Eingeleitet	Lake Street	Buy
2022-01-20	Hochstufung	Sidoti	Neutral → Buy
2021-11-18	Eingeleitet	Morgan Stanley	Underweight
2021-10-01	Eingeleitet	Jefferies	Hold
2021-08-05	Fortgesetzt	Credit Suisse	Underperform
2021-06-03	Herabstufung	Sidoti	Buy → Neutral
2021-03-05	Hochstufung	Sidoti	Neutral → Buy
2021-01-27	Herabstufung	Sidoti	Buy → Neutral
2020-08-19	Hochstufung	Sidoti	Neutral → Buy
2020-04-09	Herabstufung	Sidoti	Buy → Neutral
2020-03-12	Hochstufung	Sidoti	Neutral → Buy
2020-02-24	Herabstufung	Sidoti	Buy → Neutral
2019-08-16	Herabstufung	Craig Hallum	Buy → Hold
2018-06-15	Eingeleitet	CL King	Neutral
2017-08-24	Hochstufung	Sidoti	Neutral → Buy
2017-07-24	Hochstufung	Northcoast	Neutral → Buy
2016-05-09	Hochstufung	Craig Hallum	Sell → Hold
2016-02-04	Eingeleitet	Credit Suisse	Underperform
2010-07-19	Herabstufung	CL King	Strong Buy → Accumulate
2010-07-19	Bestätigt	JMP Securities	Mkt Outperform
2010-05-25	Herabstufung	Wedbush	Neutral → Underperform
2010-05-06	Bestätigt	Wedbush	Neutral
2010-03-23	Herabstufung	Janney Mntgmy Scott	Buy → Neutral
2010-03-18	Herabstufung	Piper Jaffray	Overweight → Neutral
2010-02-16	Bestätigt	CL King	Strong Buy
2009-07-21	Hochstufung	Piper Jaffray	Neutral → Overweight
2009-01-07	Eingeleitet	CL King	Strong Buy

Alle ansehen

Petmed Express Inc Aktie (PETS) Neueste Nachrichten

Jun 04, 2026

PetMed Express (PETS) Q4 2026 Earnings Transcript - AOL.com

Jun 04, 2026

Jun 03, 2026

PetMed outlines $6.1M annualized savings while staying independent after $4-$4.25 proposals - MSN

Jun 03, 2026

Q4 2026 Petmed Express Inc Earnings Call Transcript - GuruFocus

Jun 03, 2026

PetMeds 2026 Annual Report: Strategic Growth, Customer Care, and Competitive Position in Pet Pharmacy E-Commerce - Minichart

Jun 03, 2026

PetMed Express earnings missed by $0.06, revenue fell short of estimates - Investing.com Canada

Jun 02, 2026

PetMed FQ4 profit misses outlook, dismisses acquisition offers (PETS:NASDAQ) - Seeking Alpha

Jun 02, 2026

PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Jun 02, 2026

PETMED EXPRESS INC FY 2026: Revenue $179.02M, EPS ($2.74) — 10-K Summary - TradingView

Jun 02, 2026

PetMed Express (NASDAQ: PETS) highlights going-concern review and control weaknesses - Stock Titan

Jun 02, 2026

PetMed Express Reports Q4 2026 Results: Full Earnings Call Transcript - Benzinga

Jun 02, 2026

PetMed: Fiscal Q4 Earnings Snapshot - marketscreener.com

Jun 02, 2026

PetMed Express reports FY2026 sales $179.0M, net loss $57.3M; Q4 sales $42.8M - TradingView

Jun 02, 2026

PetMed Express misses Q4 earnings, revenue estimates; Shares edge lower By Investing.com - Investing.com India

Jun 02, 2026

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results - The Manila Times

Jun 02, 2026

PetMed Express Q4 revenue falls on prescription sales decline - TradingView

Jun 02, 2026

PetMed Express misses Q4 earnings, revenue estimates; Shares edge lower - Investing.com

Jun 02, 2026

PetMed Express (PETS) revenue falls 21% as goodwill charge drives $57M loss - Stock Titan

Jun 02, 2026

BRIEF-Petmed Express Q4 Revenue USD 42.8 Million - TradingView

Jun 02, 2026

PetMeds rejects $4.00–$4.25 a share bids, remains independent - Stock Titan

Jun 02, 2026